FR2878850B1 - DERIVATIVES OF INOSITOL-1-PHOSPHATE - Google Patents

DERIVATIVES OF INOSITOL-1-PHOSPHATE

Info

Publication number
FR2878850B1
FR2878850B1 FR0412797A FR0412797A FR2878850B1 FR 2878850 B1 FR2878850 B1 FR 2878850B1 FR 0412797 A FR0412797 A FR 0412797A FR 0412797 A FR0412797 A FR 0412797A FR 2878850 B1 FR2878850 B1 FR 2878850B1
Authority
FR
France
Prior art keywords
inositol
phosphate
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0412797A
Other languages
French (fr)
Other versions
FR2878850A1 (en
Inventor
Herve Bazin
Herve Ansanay
Eric Trinquet
Gerard Mathis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIS Bio International SA
Original Assignee
CIS Bio International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CIS Bio International SA filed Critical CIS Bio International SA
Priority to FR0412797A priority Critical patent/FR2878850B1/en
Priority to PCT/FR2005/051032 priority patent/WO2006059052A2/en
Priority to US11/792,135 priority patent/US8178704B2/en
Priority to JP2007543894A priority patent/JP5443689B2/en
Priority to EP05824048.2A priority patent/EP1817319B1/en
Priority to ES05824048T priority patent/ES2424682T3/en
Publication of FR2878850A1 publication Critical patent/FR2878850A1/en
Application granted granted Critical
Publication of FR2878850B1 publication Critical patent/FR2878850B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR0412797A 2004-12-02 2004-12-02 DERIVATIVES OF INOSITOL-1-PHOSPHATE Active FR2878850B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0412797A FR2878850B1 (en) 2004-12-02 2004-12-02 DERIVATIVES OF INOSITOL-1-PHOSPHATE
PCT/FR2005/051032 WO2006059052A2 (en) 2004-12-02 2005-12-02 Inositol-phosphate derivatives and method of detecting inositol-1-phosphate
US11/792,135 US8178704B2 (en) 2004-12-02 2005-12-02 Inositol-phosphate derivatives and method of detecting inositol-1-phosphate
JP2007543894A JP5443689B2 (en) 2004-12-02 2005-12-02 Method for detecting inositol phosphate derivative and inositol-1-phosphate
EP05824048.2A EP1817319B1 (en) 2004-12-02 2005-12-02 Inositol-phosphate derivatives and method of detecting inositol-1-phosphate
ES05824048T ES2424682T3 (en) 2004-12-02 2005-12-02 Inositol phosphate derivatives and inositol-1-phosphate detection procedure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0412797A FR2878850B1 (en) 2004-12-02 2004-12-02 DERIVATIVES OF INOSITOL-1-PHOSPHATE

Publications (2)

Publication Number Publication Date
FR2878850A1 FR2878850A1 (en) 2006-06-09
FR2878850B1 true FR2878850B1 (en) 2008-10-31

Family

ID=34954447

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0412797A Active FR2878850B1 (en) 2004-12-02 2004-12-02 DERIVATIVES OF INOSITOL-1-PHOSPHATE

Country Status (6)

Country Link
US (1) US8178704B2 (en)
EP (1) EP1817319B1 (en)
JP (1) JP5443689B2 (en)
ES (1) ES2424682T3 (en)
FR (1) FR2878850B1 (en)
WO (1) WO2006059052A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013305907B2 (en) 2012-08-21 2018-01-18 Saladax Biomedical Inc. Antibodies to quetiapine and use thereof
CA2882597C (en) 2012-08-21 2020-04-14 Ortho-Clinical Diagnostics, Inc. Antibodies to quetiapine haptens and use thereof
PT2888258T (en) * 2012-08-21 2019-08-21 Janssen Pharmaceutica Nv Haptens of paliperidone
ES2645433T3 (en) * 2012-08-21 2017-12-05 Janssen Pharmaceutica, N.V. Quepiapine haptenos for use in immunoassays
GB201311989D0 (en) * 2013-07-04 2013-08-21 Univ St Andrews Inositol biotransformation
KR101398764B1 (en) 2013-08-29 2014-05-27 강릉원주대학교산학협력단 Device for detecting analytes by moving the particle and method using the same
WO2017106508A1 (en) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
CN107132348A (en) * 2017-02-22 2017-09-05 江苏雷森生物科技有限公司 A kind of method of color fluorescence particle marker antibody and the test strips prepared using it
BR112020001938A2 (en) * 2017-07-31 2020-08-04 Cj Cheiljedang Corporation new psychosis-6-phosphate phosphatase, composition for the production of psychosis, including said enzyme, method for the production of psychosis using the enzyme
CN109061156B (en) * 2018-09-21 2021-07-13 中国烟草总公司郑州烟草研究院 Time-resolved fluorescence immunochromatographic test strip for detecting pendimethalin and preparation method and application thereof
CN109061147B (en) * 2018-09-21 2021-04-13 中国烟草总公司郑州烟草研究院 Test strip for detecting pendimethalin and preparation method and application thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (en) 1984-09-26 1988-07-08 Commissariat Energie Atomique RARE EARTH MACROPOLYCYCLIC COMPLEXES AND APPLICATION AS FLUORESCENT MARKERS
FR2624862B1 (en) 1987-12-18 1990-06-08 Oris Ind RARE EARTH CRYPTATES, PROCESSES FOR OBTAINING SYNTHESIS INTERMEDIATES, AND APPLICATION AS FLUORESCENT MARKERS
US5264605A (en) 1989-06-28 1993-11-23 Mitsui Toatsu Chemicals, Incorporated Myoinsitol derivatives, process for preparing same, phosphorylating agent, and its utilization
FR2672128B1 (en) 1991-01-28 1995-08-18 Cis Bio Int METHOD FOR MEASURING THE LUMINESCENCE EMITTED IN A LUMINESCENCE ASSAY.
FR2680787B1 (en) 1991-08-30 1994-11-04 Cis Bio Int MACROCYCLIC RARE EARTH COMPLEXES AND THEIR USE FOR REDUCING INTERFERENCE IN FLUORESCENCE ASSAY.
WO1996021440A1 (en) * 1995-01-09 1996-07-18 Alpha-Therapeutics, Inc. Methods for increasing the bioavailability of biological active agents
DE19649350A1 (en) * 1996-11-28 1998-06-04 Hoechst Ag Inositol glycans with an insulin-like effect
GB9828565D0 (en) * 1998-12-23 1999-02-17 Rademacher Group Limited Inositol-containing hexasaccharidies,their synthesis and their uses
US6759390B2 (en) * 2000-05-12 2004-07-06 Manuel Martin-Lomas Compounds and their uses
EP1406913A2 (en) * 2000-05-12 2004-04-14 Rodaris Pharmaceuticals Limited Inositolglycans and their uses
AU2002253441A1 (en) * 2002-04-12 2003-10-27 Silbiotec Due S.A. Medicaments containing glycerophosphoinositol-4-phosphate derivatives
AU2003301583A1 (en) 2002-10-21 2004-05-13 Discoverx, Inc. Ip3 protein binding assay

Also Published As

Publication number Publication date
JP2008521867A (en) 2008-06-26
EP1817319B1 (en) 2013-07-03
US20080261237A1 (en) 2008-10-23
FR2878850A1 (en) 2006-06-09
US8178704B2 (en) 2012-05-15
EP1817319A2 (en) 2007-08-15
ES2424682T3 (en) 2013-10-07
JP5443689B2 (en) 2014-03-19
WO2006059052A3 (en) 2006-10-05
WO2006059052A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
CY2022001I1 (en) DERIVATIVE OF UK-2A
FR20C1027I2 (en) DERIVATIVES OF TIGLIEN-3-ONE
CY2017048I2 (en) NEW PHARMACEUTICAL USES OF STAVROSPORINE DERIVATIVES
ATE340782T1 (en) PIPERIDINEBENZENESULFONAMIDE DERIVATIVES
NO20054136D0 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
ATE420066T1 (en) AMIDOACETONITRIL DERIVATIVES
DE602004015724D1 (en) DIAZEPINOINDOL DERIVATIVES AS KINASEINHIBITORS
IS8180A (en) New besimidasol derivatives
DE602004024420D1 (en) CHINAZOLINE DERIVATIVES AS ANTITUM-AGENT
ATE352550T1 (en) CHINAZOLINE DERIVATIVES
MA28824B1 (en) PYRIMIDINE DERIVATIVES
DK1802579T3 (en) Derivatives of 3-arylaminopyridine
ATE499347T1 (en) AMIDE DERIVATIVES
MA28813B1 (en) PYRIMIDINE DERIVATIVES
MA28816B1 (en) NOVEL 4-BENZYLIDENE-PIPERIDINE DERIVATIVES
DE602004022180D1 (en) quinazoline derivatives
IS8364A (en) N-thiazol-2-yl-benzamide derivatives
DK1652843T3 (en) amide derivatives
IS8045A (en) Purin-6-one derivatives
FR2878850B1 (en) DERIVATIVES OF INOSITOL-1-PHOSPHATE
DK1706373T3 (en) Amidoacetonitrile derivatives
ATE394372T1 (en) G-LACTAM DERIVATIVES AS PROSTAGLAND INAGONISTS
MA28812B1 (en) COMBINATIONS OF EPOTHILONE
ATE389652T1 (en) BENZOTHIAZOLE DERIVATIVES AS LIGANDS OF THE ADENOSINE RECEPTOR
FR2877833B1 (en) CORRECTEUR OF LORDOSES

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20